John M. Climaco
Board Member
CNS Pharmaceuticals, Inc. (CNSP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Start not stated–2025-12-16
-
Start not stated–2025-12-16
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $1,103,680 |
| 2023 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $624,348 |
| 2022 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $827,928 |
| 2021 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $525,000 | $845,940 |
| 2020 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $440,000 | $1,572,908 |
| 2019 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $213,867 | $1,229,304 |
| 2018 | CNS Pharmaceuticals, Inc. (CNSP) | CEO | $150,000 | $164,300 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.